Recruiting studies: Mmr Mutation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.
Phase N/A · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT05097274 Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429 NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
Phase 2 · 6 location(s) · University College, London · NCT05197322 Small Bowel Capsule Endoscopy in Lynch Syndrome
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07472686 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · 17 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT05093231 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
EARLY_Phase 1 · 5 location(s) · Radiopharm Theranostics, Ltd · NCT06305962 A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692 Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
Phase N/A · 4 location(s) · San Raffaele University · NCT07450612 Prostate Cancer Genetic Risk Evaluation and Screening Study
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT05129605

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.